Bavarian Nordic vaccine helps prolong life in prostate cancer trial

Feb 24 (Reuters) - An experimental therapeutic vaccine from Danish drugmaker Bavarian Nordic helped significantly extend survival in patients with advanced prostate cancer, according to results of a...

from Reuters: Hot Stocks http://ift.tt/1w8IiIz